Skip to main content
. 2020 Nov 24;11:598789. doi: 10.3389/fmicb.2020.598789

FIGURE 4.

FIGURE 4

Anti-biofilm activity of CMB001. (A) Viability of pre-formed biofilms when treated with CMB001 or vancomycin S. aureus ATCC 29213 (SA) and MDR strain CH-11. (B) Inhibition of bacterial (S. aureus ATCC 29213) adhesion to a surface at 1- and 24-h following pre-coating with CMB001.